Stålnacke Sanna, Liira Helena, Vangelova-Korpinen Velina, Virrantaus Hélène, Kanerva Mari, Kvarnström Kirsi, Sainio Markku, Malmivaara Antti, Vuokko Aki, Varonen Mikko, Venäläinen Mikko, Arokoski Jari
Outpatient Clinic for Persistent Symptom Rehabilitation, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Turku University Hospital and University, Turku, Finland.
Scand J Prim Health Care. 2025 Mar;43(1):155-163. doi: 10.1080/02813432.2024.2410986. Epub 2024 Oct 3.
After COVID-19 infection, long-term impacts on functioning may occur. We studied the functioning of patients with post-COVID-19 condition (PCC) and compared them to controls without PCC.
This cross-sectional study consisted of 442 patients with PCC referred to rehabilitation at the Helsinki University Hospital (HUS) Outpatient Clinic for the Long-Term Effects of COVID-19, and 198 controls without PCC. Functioning was assessed with a questionnaire including WHODAS 2.0. Patients underwent physical testing including a hand grip strength test (HGST) and a 6-minute walking test (6MWT). Lifestyle was assessed by questionnaire and comorbidities were collected as ICD-10 codes from the HUS Data Lake on the HUS Acamedic platform.
The WHODAS 2.0 average total score was 34 (SD 18) (moderate functional limitation) for patients with PCC and 6 (SD 8) (normal or mild limitation) for the controls. The disability was higher in all aspects of WHODAS 2.0 in patients with PCC. Bivariate binomial and multivariable regression analyses showed that the presence of comorbidities, anxiety, depression, and smoking predicted a WHODAS 2.0 score of 24 (moderate functional limitation) or above in the PCC group. The average 6MWT distance was 435 m (SD 98 m) in patients with PCC and 627 m (SD 70 m) in controls. HGST measurements showed no significant differences from controls.
In conclusion, patients with PCC had significantly reduced functioning based on WHODAS 2.0 scores and the 6MWT results. Comorbidities, anxiety, depression, and smoking were associated with moderate or severe limitations in functioning. Findings support that PCC is multifactorial and requires a holistic approach to rehabilitation.
新型冠状病毒肺炎(COVID-19)感染后,可能会对身体机能产生长期影响。我们研究了感染COVID-19后状况(PCC)患者的身体机能,并将他们与无PCC的对照组进行比较。
这项横断面研究包括442名因COVID-19长期影响而转诊至赫尔辛基大学医院(HUS)门诊进行康复治疗的PCC患者,以及198名无PCC的对照组。使用包括世界卫生组织残疾评定量表2.0(WHODAS 2.0)在内的问卷评估身体机能。患者接受了身体测试,包括握力测试(HGST)和6分钟步行测试(6MWT)。通过问卷评估生活方式,并从HUS学术平台上的HUS数据湖中收集国际疾病分类第10版(ICD-10)编码的合并症。
PCC患者的WHODAS 2.0平均总分是34(标准差18)(中度功能受限),对照组为6(标准差8)(正常或轻度受限)。PCC患者在WHODAS 2.0的各个方面残疾程度都更高。二元二项式和多变量回归分析表明,合并症、焦虑、抑郁和吸烟可预测PCC组的WHODAS 2.0评分为24(中度功能受限)或更高。PCC患者的平均6MWT距离为435米(标准差98米),对照组为627米(标准差70米)。HGST测量结果与对照组无显著差异。
总之,基于WHODAS 2.0评分和6MWT结果,PCC患者的身体机能显著下降。合并症、焦虑、抑郁和吸烟与中度或重度功能受限有关。研究结果支持PCC是多因素的,需要采取整体康复方法。